Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by HOSPIRA INC
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
017957
NOVAMINE 11.4%
NOVAMINE 15%
NOVAMINE 8.5%
VEINAMINE 8%
New Drug Application
Approval
New formulation
(S) Standard review drug
018406
PHYSIOSOL IN PLASTIC CONTAINER
PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019008
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
New Drug Application
Approval
New formulation
(S) Standard review drug
019211
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019682
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019683
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
020122
NIPENT
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
022234
DOCETAXEL
New Drug Application
Approval
New manufacturer
(S) Standard review drug
040793
A-METHAPRED
Abbreviated New Drug Application
Approval
040806
MEPIVACAINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
040827
A-METHAPRED
Abbreviated New Drug Application
Approval
050679
MAXIPIME
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
065226
CEFAZOLIN SODIUM
Abbreviated New Drug Application
Approval
065230
CEFTRIAXONE
Abbreviated New Drug Application
Approval
065231
CEFTRIAXONE
Abbreviated New Drug Application
Approval
065232
CEFTRIAXONE
Abbreviated New Drug Application
Approval
065244
CEFAZOLIN SODIUM
Abbreviated New Drug Application
Approval
065247
CEFAZOLIN SODIUM
Abbreviated New Drug Application
Approval
065290
CEFOTAXIME SODIUM
Abbreviated New Drug Application
Approval
065292
CEFOTAXIME SODIUM
Abbreviated New Drug Application
Approval
065293
CEFOTAXIME SODIUM
Abbreviated New Drug Application
Approval
065312
CEFOXITIN
Abbreviated New Drug Application
Approval
065313
CEFOXITIN
Abbreviated New Drug Application
Approval
065369
CEFEPIME HYDROCHLORIDE
Abbreviated New Drug Application
Approval
065386
PIPERACILLIN AND TAZOBACTAM
Abbreviated New Drug Application
Approval
065446
PIPERACILLIN AND TAZOBACTAM
Abbreviated New Drug Application
Approval
065455
VANCOMYCIN HYDROCHLORIDE
Abbreviated New Drug Application
Approval
065483
CEFUROXIME SODIUM
Abbreviated New Drug Application
Approval
065484
CEFUROXIME SODIUM
Abbreviated New Drug Application
Approval
065503
CEFUROXIME SODIUM
Abbreviated New Drug Application
Approval
075409
MIDAZOLAM HYDROCHLORIDE
Abbreviated New Drug Application
Approval
078577
LEVOFLOXACIN
Abbreviated New Drug Application
Approval
078579
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Abbreviated New Drug Application
Approval
078591
HYDROMORPHONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
078815
OXALIPLATIN
Abbreviated New Drug Application
Approval
079183
GEMCITABINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
090375
AMPICILLIN AND SULBACTAM
Abbreviated New Drug Application
Approval
090571
HEPARIN SODIUM
Abbreviated New Drug Application
Approval
090621
ZOLEDRONIC ACID
Abbreviated New Drug Application
Approval
090646
AMPICILLIN AND SULBACTAM
Abbreviated New Drug Application
Approval
090653
AMPICILLIN AND SULBACTAM
Abbreviated New Drug Application
Approval
090709
ZOLEDRONIC ACID
Abbreviated New Drug Application
Tentative Approval
090761
ATRACURIUM BESYLATE
Abbreviated New Drug Application
Approval
090782
ATRACURIUM BESYLATE PRESERVATIVE FREE
Abbreviated New Drug Application
Approval
090811
BIVALIRUDIN
Abbreviated New Drug Application
Approval
090816
BIVALIRUDIN
Abbreviated New Drug Application
Approval
090825
IMIPENEM AND CILASTATIN
Abbreviated New Drug Application
Approval
090940
MEROPENEM
Abbreviated New Drug Application
Approval
091007
IMIPENEM AND CILASTATIN
Abbreviated New Drug Application
Approval
200403
HYDROMORPHONE HYDROCHLORIDE
New Drug Application
Approval
Drug already marketed, but without an approved NDA
(S) Standard review drug
200582
TOPOTECAN HYDROCHLORIDE
New Drug Application
Approval
New manufacturer
(S) Standard review drug
200795
GEMCITABINE HYDROCHLORIDE
New Drug Application
Approval
New formulation
(S) Standard review drug
201654
CEFAZOLIN SODIUM
Abbreviated New Drug Application
Approval
201657
PARICALCITOL
New Drug Application
Approval
New manufacturer
(S) Standard review drug
202111
PEMETREXED DISODIUM
Abbreviated New Drug Application
Tentative Approval
202268
CEFEPIME HYDROCHLORIDE
Abbreviated New Drug Application
Approval
202411
MAGNESIUM SULFATE
Abbreviated New Drug Application
Approval
202515
MORPHINE SULFATE
New Drug Application
Approval
Drug already marketed, but without an approved NDA
(S) Standard review drug
202563
CEFTRIAXONE
Abbreviated New Drug Application
Approval
202837
ZOLEDRONIC ACID
Abbreviated New Drug Application
Approval
202857
DAPTOMYCIN
Abbreviated New Drug Application
Approval
202864
AMPICILLIN SODIUM
Abbreviated New Drug Application
Approval
202865
AMPICILLIN SODIUM
Abbreviated New Drug Application
Approval
202869
LEVETIRACETAM
Abbreviated New Drug Application
Approval
202981
SODIUM BICARBONATE
Abbreviated New Drug Application
Approval
203132
CEFOTAXIME SODIUM
Abbreviated New Drug Application
Approval
203280
MILRINONE LACTATE
Abbreviated New Drug Application
Approval
203797
DAPTOMYCIN
New Drug Application
Tentative Approval
New manufacturer
(S) Standard review drug
203883
ADENOSINE
Abbreviated New Drug Application
Approval
203884
AMIODARONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
203885
AMIODARONE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
203950
OXACILLIN SODIUM
Abbreviated New Drug Application
Approval
204016
ZOLEDRONIC ACID
New Drug Application
Approval
New manufacturer
(S) Standard review drug
204086
BENDAMUSTINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
204118
INDOMETHACIN SODIUM
Abbreviated New Drug Application
Approval
204120
ARGATROBAN
Abbreviated New Drug Application
Approval
205442
LINEZOLID
Abbreviated New Drug Application
Approval
206473
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval